BioCopy AG

BioCopy is a multinational company and focuses on TCR(m)- based immuno-oncology drug development. The BioCopy group is headquartered in Switzerland. The German branch, including a state-of-the-art research and development facility, is situated in Emmendingen, north of Freiburg i. Br.

We are successfully using our unique platform technology based on extensive expertise in microarray customization, binding kinetics and bioinformatics. Our team of experts is continuously working on improving the proprietary inhouse technologies for the fast, efficient and accurate characterization and development of TCR(m)-based immuno-oncology drugs.